Sihuan Pharmaceutical Holdings Group Ltd. (HKG:0460)

Market Cap	13.45B
Revenue (ttm)	2.30B
Net Income (ttm)	-88.36M
Shares Out	9.09B
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	135.44
Dividend	0.02 (1.43%)
Ex-Dividend Date	Sep 26, 2025

Volume	29,767,242
Average Volume	59,099,241
Open	1.510
Previous Close	1.510
Day's Range	1.480 - 1.540
52-Week Range	0.530 - 1.920
Beta	0.61
RSI	45.00
Earnings Date	Nov 28, 2025

About HKG:0460

Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical and medical aesthetic products in the People’s Republic of China and the United States. It operates through three segments: Medical Aesthetic Products, Innovative Medicine and Other Medicine, and Generic Medicine. The company offers filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skin care, and others, as well as non- or minimally invasive medical aesthet...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2001
• Employees: 2,667
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 0460

Financial Performance

In 2024, HKG:0460's revenue was 1.90 billion, an increase of 2.18% compared to the previous year's 1.86 billion. Losses were -216.66 million, 301.1% more than in 2023.

Financial numbers in CNY